Send the following on WhatsApp
Continue to ChatComparison of low dose cytosine arabinoside, azacitidine and azacitidine venetoclax combination treatment as remission induction in elderly acute myeloid leukemia patients - https://dergipark.org.tr/tr/pub/jompac/issue/82256/1365715